 Soluble receptor agent serum-mediated suppression human visceral leishmaniasis visceral leishmaniasis VL patient lymphocytes leishmania Ag stimulation sera exhibit potent nonspecific suppressive effect responses normal lymphocytes Sera VL patients patients subclinical VL normal volunteers sera VL patients Con A-induced lymphocyte proliferative responses IFN-gamma production normal lymphocytes Addition exogenous human cultures VL patient sera normal lymphocyte proliferative capacity IFN-gamma production phenomenon consistent presence elevated levels soluble VL patients sera U/ml normal sera U/ml sera patients subclinical leishmania infection immunosuppression U/ml removal VL serum suppressive activity effects IFN-gamma production data participation high levels serum-mediated suppression VL